Zinc treatment of outpatient COVID-19: A retrospective review of 28 consecutive patients
- PMID: 33475170
- PMCID: PMC8013504
- DOI: 10.1002/jmv.26812
Zinc treatment of outpatient COVID-19: A retrospective review of 28 consecutive patients
Keywords: COVID-19; SARS-Cov-2; retrospective; treatment; zinc.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- Lanke K1, Krenn BM, Melchers WJ, Seipelt J, Kuppeveld FJ. PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. J Gen Virol. 2007;88(Pt 4):1206‐1217. - PubMed
-
- Carlucci P, Tania T, Petrilli, et al. Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID‐19 patients Medrxiv. 10.1101/2020.05.02.20080036 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
